# Outlook Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 28, 2025

- Company: [Outlook Therapeutics, Inc.](/companies/otlk.md) (CIK 1649989)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-28
- Accepted by EDGAR: May 28, 2025, 21:24 ET
- Period: not reported
- Accession: 0000947871-25-000572
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1649989/000094787125000572/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649989/000094787125000572/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649989/000094787125000572/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 28, 2025.
Source: SEC EDGAR, the filing index for accession 0000947871-25-000572. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
